Amphastar Pharmaceuticals, Inc. (AMPH) stock
AMPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3033% below fair value
$28.60−0.46 (-1.58%)
Close on Nov 11, 2026Market cap $1.22BP/E 13.0Yield –
Amphastar Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Amphastar Pharmaceuticals's enterprise value was $1.54B on Nov 11, 2026, against $1.62B a year earlier. Over the last 5 years it ranged from $1.07B to $3.31B, with a median of $1.62B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.54B | -2.3% |
| 2025 | Dec 31, 2025 | $1.57B | -26.5% |
| 2024 | Dec 31, 2024 | $2.14B | -35.3% |
| 2023 | Dec 29, 2023 | $3.31B | +164.2% |
| 2022 | Dec 30, 2022 | $1.25B | +16.0% |
| 2021 | Dec 31, 2021 | $1.08B | +14.2% |
| 2020 | Dec 31, 2020 | $946.07M | +5.2% |
| 2019 | Dec 31, 2019 | $899.64M | -2.0% |
| 2018 | Dec 31, 2018 | $918.20M | +6.7% |
| 2017 | Dec 29, 2017 | $860.18M | +4.5% |
| 2016 | Dec 30, 2016 | $823.27M | +33.1% |
| 2015 | Dec 31, 2015 | $618.72M | +24.5% |
| 2014 | Dec 31, 2014 | $496.80M | – |
See a number that looks wrong?